Share Price and Basic Stock Data
Last Updated: October 20, 2025, 6:55 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Sanginita Chemicals Ltd operates in the organic chemicals sector, focusing on manufacturing and distribution. As of the latest financial reporting period, the company’s sales for FY 2025 stood at ₹230 Cr, compared to ₹149 Cr in FY 2023, indicating a notable increase in revenue over the two-year period. The quarterly sales data shows fluctuations, with the highest sales recorded at ₹61.34 Cr in September 2024, while the lowest was ₹29.16 Cr in December 2023. The company has faced challenges in maintaining consistent sales, as evidenced by the sharp decline from ₹51.09 Cr in June 2022 to ₹30.14 Cr in September 2022. Despite this, the trailing twelve months (TTM) revenue was reported at ₹219 Cr, suggesting a recovery trend. The company’s operational performance is further highlighted by an operating profit margin (OPM) of 2% for FY 2025, reflecting the competitive nature of the sector, which often sees margins in the range of 5-10% for more established players.
Profitability and Efficiency Metrics
Regarding profitability, Sanginita Chemicals reported a net profit of ₹1 Cr for FY 2025, a recovery from a net loss in FY 2023, where the company recorded a loss of ₹0.10 Cr. The earnings per share (EPS) for FY 2025 was ₹0.24, slightly declining from ₹0.30 in FY 2024. The return on equity (ROE) stood at a modest 1.28%, while the return on capital employed (ROCE) was reported at 4.19%, both indicating low profitability relative to equity and capital employed. The company’s interest coverage ratio (ICR) was recorded at 2.03x, suggesting that it generates sufficient operating income to cover interest expenses, which is a positive indicator of financial health. However, the cash conversion cycle of 85 days raises concerns about liquidity and operational efficiency, as it reflects the time taken to convert investments in inventory and accounts receivable into cash.
Balance Sheet Strength and Financial Ratios
Sanginita Chemicals’ balance sheet reflects a total market capitalization of ₹26.5 Cr, with total borrowings reported at ₹26 Cr and reserves at ₹30 Cr. The company’s debt-to-equity ratio stands at 0.46, indicating a moderate level of leverage. The current ratio is reported at 1.93, suggesting that the company has adequate short-term assets to cover its liabilities, while the quick ratio of 1.27 indicates a strong liquidity position. The price-to-book value (P/BV) ratio is at 0.41x, suggesting that the stock is undervalued compared to its book value, which could attract investment interest. However, the operating profit margin (OPM) of 2% is below the industry average, pointing to challenges in cost management and pricing strategy. The company’s efficiency metrics, including an inventory turnover ratio of 4.40x, indicate a relatively healthy inventory management system, although there is room for improvement in receivables management.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Sanginita Chemicals reveals a significant ownership shift, with promoters holding 37.24% as of March 2025, down from 62.68% in September 2022. This reduction may raise concerns about insider confidence and commitment to the company. The public’s shareholding has increased substantially to 62.76%, suggesting growing interest from retail investors, which could be a positive indicator for future liquidity. The number of shareholders has seen a considerable rise, increasing from 9,826 in September 2022 to 16,791 by March 2025, reflecting enhanced investor participation. However, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) may indicate a lack of institutional confidence in the company’s long-term prospects. This could hinder the stock’s ability to attract larger investments and stabilize its market performance.
Outlook, Risks, and Final Insight
If margins sustain and operational efficiencies improve, Sanginita Chemicals could position itself for more robust financial performance. The company faces risks related to its high cash conversion cycle, which may impact liquidity and operational flexibility. Additionally, the declining promoter shareholding could signal potential governance issues or a lack of strategic direction. However, an increasing public stake presents an opportunity for the company to enhance its retail investor base, which could provide stability and support for future growth. If the company successfully implements cost control measures and enhances its sales strategies, it may improve profitability metrics and regain investor confidence. Overall, while there are significant challenges, strategic initiatives could enable Sanginita Chemicals to navigate the competitive landscape effectively.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Sanginita Chemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 123 Cr. | 345 | 475/255 | 127 | 390 | 0.03 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,788 Cr. | 9,824 | 14,284/8,150 | 58.6 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 37.7 Cr. | 126 | 329/114 | 15.2 | 24.9 | 0.80 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.0 Cr. | 35.8 | 35.8/35.8 | 35.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 257 Cr. | 321 | 385/134 | 19.8 | 94.6 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,459.86 Cr | 1,680.76 | 405.73 | 326.96 | 0.36% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 51.09 | 30.14 | 33.51 | 33.82 | 35.90 | 33.41 | 29.16 | 53.04 | 56.95 | 61.34 | 61.54 | 49.85 | 45.91 |
| Expenses | 50.31 | 29.57 | 32.40 | 33.24 | 34.69 | 31.98 | 27.94 | 52.94 | 55.67 | 60.08 | 60.38 | 48.87 | 45.11 |
| Operating Profit | 0.78 | 0.57 | 1.11 | 0.58 | 1.21 | 1.43 | 1.22 | 0.10 | 1.28 | 1.26 | 1.16 | 0.98 | 0.80 |
| OPM % | 1.53% | 1.89% | 3.31% | 1.71% | 3.37% | 4.28% | 4.18% | 0.19% | 2.25% | 2.05% | 1.88% | 1.97% | 1.74% |
| Other Income | 0.16 | 0.25 | 0.05 | 0.11 | 0.07 | 0.08 | 0.25 | 0.04 | 0.04 | 0.13 | 0.08 | 0.01 | 0.37 |
| Interest | 0.59 | 0.60 | 0.63 | 0.68 | 0.66 | 0.62 | 0.66 | 0.68 | 0.64 | 0.63 | 0.58 | 0.59 | 0.53 |
| Depreciation | 0.14 | 0.14 | 0.14 | 0.14 | 0.15 | 0.16 | 0.20 | 0.24 | 0.26 | 0.47 | 0.48 | 0.47 | 0.54 |
| Profit before tax | 0.21 | 0.08 | 0.39 | -0.13 | 0.47 | 0.73 | 0.61 | -0.78 | 0.42 | 0.29 | 0.18 | -0.07 | 0.10 |
| Tax % | 23.81% | 25.00% | 23.08% | -30.77% | 25.53% | 26.03% | 26.23% | -24.36% | 26.19% | 24.14% | 27.78% | -14.29% | -10.00% |
| Net Profit | 0.16 | 0.06 | 0.29 | -0.10 | 0.35 | 0.54 | 0.46 | -0.58 | 0.31 | 0.22 | 0.14 | -0.05 | 0.11 |
| EPS in Rs | 0.06 | 0.02 | 0.11 | -0.04 | 0.14 | 0.21 | 0.18 | -0.22 | 0.12 | 0.08 | 0.05 | -0.02 | 0.04 |
Last Updated: August 1, 2025, 12:30 pm
Below is a detailed analysis of the quarterly data for Sanginita Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 45.91 Cr.. The value appears to be declining and may need further review. It has decreased from 49.85 Cr. (Mar 2025) to 45.91 Cr., marking a decrease of 3.94 Cr..
- For Expenses, as of Jun 2025, the value is 45.11 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 48.87 Cr. (Mar 2025) to 45.11 Cr., marking a decrease of 3.76 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.80 Cr.. The value appears to be declining and may need further review. It has decreased from 0.98 Cr. (Mar 2025) to 0.80 Cr., marking a decrease of 0.18 Cr..
- For OPM %, as of Jun 2025, the value is 1.74%. The value appears to be declining and may need further review. It has decreased from 1.97% (Mar 2025) to 1.74%, marking a decrease of 0.23%.
- For Other Income, as of Jun 2025, the value is 0.37 Cr.. The value appears strong and on an upward trend. It has increased from 0.01 Cr. (Mar 2025) to 0.37 Cr., marking an increase of 0.36 Cr..
- For Interest, as of Jun 2025, the value is 0.53 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.59 Cr. (Mar 2025) to 0.53 Cr., marking a decrease of 0.06 Cr..
- For Depreciation, as of Jun 2025, the value is 0.54 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.47 Cr. (Mar 2025) to 0.54 Cr., marking an increase of 0.07 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.10 Cr.. The value appears strong and on an upward trend. It has increased from -0.07 Cr. (Mar 2025) to 0.10 Cr., marking an increase of 0.17 Cr..
- For Tax %, as of Jun 2025, the value is -10.00%. The value appears to be increasing, which may not be favorable. It has increased from -14.29% (Mar 2025) to -10.00%, marking an increase of 4.29%.
- For Net Profit, as of Jun 2025, the value is 0.11 Cr.. The value appears strong and on an upward trend. It has increased from -0.05 Cr. (Mar 2025) to 0.11 Cr., marking an increase of 0.16 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.04. The value appears strong and on an upward trend. It has increased from -0.02 (Mar 2025) to 0.04, marking an increase of 0.06.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:30 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 119 | 129 | 151 | 155 | 197 | 188 | 160 | 164 | 197 | 149 | 151 | 230 | 201 |
| Expenses | 114 | 124 | 147 | 150 | 189 | 178 | 151 | 160 | 195 | 145 | 147 | 225 | 198 |
| Operating Profit | 5 | 4 | 5 | 5 | 8 | 9 | 8 | 4 | 3 | 3 | 4 | 5 | 3 |
| OPM % | 4% | 3% | 3% | 3% | 4% | 5% | 5% | 2% | 1% | 2% | 3% | 2% | 2% |
| Other Income | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Interest | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 2 | 2 | 3 | 2 | 2 |
| Depreciation | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Profit before tax | 1 | 1 | 2 | 2 | 5 | 5 | 4 | 1 | 0 | 1 | 1 | 1 | -0 |
| Tax % | 35% | 32% | 32% | 34% | 33% | 28% | 25% | 25% | 24% | 23% | 27% | 25% | |
| Net Profit | 1 | 1 | 1 | 1 | 3 | 4 | 3 | 1 | 0 | 0 | 1 | 1 | -0 |
| EPS in Rs | 0.68 | 0.81 | 0.87 | 0.43 | 1.33 | 1.52 | 1.30 | 0.29 | 0.14 | 0.16 | 0.30 | 0.24 | -0.19 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 0.00% | 0.00% | 200.00% | 33.33% | -25.00% | -66.67% | -100.00% | 0.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 0.00% | 0.00% | 200.00% | -166.67% | -58.33% | -41.67% | -33.33% | 100.00% |
Sanginita Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 8% |
| 3 Years: | 5% |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -29% |
| 3 Years: | 21% |
| TTM: | -42% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -31% |
| 3 Years: | -22% |
| 1 Year: | -41% |
| Return on Equity | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 1% |
| 3 Years: | 1% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 1:25 pm
Balance Sheet
Last Updated: July 25, 2025, 2:25 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 26 |
| Reserves | 6 | 7 | 8 | 11 | 14 | 18 | 21 | 22 | 22 | 23 | 24 | 30 |
| Borrowings | 23 | 23 | 25 | 26 | 26 | 29 | 35 | 29 | 35 | 29 | 33 | 26 |
| Other Liabilities | 7 | 12 | 2 | 7 | 3 | 7 | 5 | 2 | 5 | 11 | 12 | 20 |
| Total Liabilities | 44 | 50 | 44 | 60 | 61 | 72 | 78 | 70 | 79 | 80 | 86 | 102 |
| Fixed Assets | 5 | 4 | 4 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 8 | 15 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 40 | 46 | 40 | 57 | 57 | 67 | 74 | 66 | 75 | 75 | 78 | 87 |
| Total Assets | 44 | 50 | 44 | 60 | 61 | 72 | 78 | 70 | 79 | 80 | 86 | 102 |
Below is a detailed analysis of the balance sheet data for Sanginita Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2024) to 26.00 Cr., marking an increase of 9.00 Cr..
- For Reserves, as of Mar 2025, the value is 30.00 Cr.. The value appears strong and on an upward trend. It has increased from 24.00 Cr. (Mar 2024) to 30.00 Cr., marking an increase of 6.00 Cr..
- For Borrowings, as of Mar 2025, the value is 26.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 33.00 Cr. (Mar 2024) to 26.00 Cr., marking a decrease of 7.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 20.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.00 Cr. (Mar 2024) to 20.00 Cr., marking an increase of 8.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 102.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 86.00 Cr. (Mar 2024) to 102.00 Cr., marking an increase of 16.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2024) to 15.00 Cr., marking an increase of 7.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 87.00 Cr.. The value appears strong and on an upward trend. It has increased from 78.00 Cr. (Mar 2024) to 87.00 Cr., marking an increase of 9.00 Cr..
- For Total Assets, as of Mar 2025, the value is 102.00 Cr.. The value appears strong and on an upward trend. It has increased from 86.00 Cr. (Mar 2024) to 102.00 Cr., marking an increase of 16.00 Cr..
Notably, the Reserves (30.00 Cr.) exceed the Borrowings (26.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -18.00 | -19.00 | -20.00 | -21.00 | -18.00 | -20.00 | -27.00 | -25.00 | -32.00 | -26.00 | -29.00 | -21.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 64 | 86 | 64 | 96 | 66 | 62 | 89 | 65 | 46 | 63 | 64 | 58 |
| Inventory Days | 48 | 41 | 30 | 29 | 29 | 39 | 50 | 51 | 46 | 70 | 76 | 49 |
| Days Payable | 14 | 32 | 2 | 15 | 3 | 8 | 7 | 2 | 8 | 25 | 27 | 22 |
| Cash Conversion Cycle | 98 | 95 | 93 | 109 | 92 | 93 | 132 | 114 | 84 | 107 | 112 | 85 |
| Working Capital Days | 99 | 34 | 33 | 58 | 52 | 60 | 78 | 78 | 72 | 81 | 86 | 67 |
| ROCE % | 12% | 11% | 11% | 10% | 14% | 14% | 11% | 5% | 4% | 4% | 5% | 4% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.24 | 0.45 | 0.24 | 0.20 | 0.44 |
| Diluted EPS (Rs.) | 0.24 | 0.45 | 0.24 | 0.20 | 0.44 |
| Cash EPS (Rs.) | 0.88 | 0.87 | 0.56 | 0.53 | 0.82 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 21.68 | 23.62 | 23.24 | 23.00 | 22.80 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 21.68 | 23.62 | 23.24 | 23.00 | 22.80 |
| Revenue From Operations / Share (Rs.) | 88.67 | 87.74 | 86.03 | 114.70 | 95.36 |
| PBDIT / Share (Rs.) | 1.91 | 2.55 | 2.09 | 1.80 | 2.46 |
| PBIT / Share (Rs.) | 1.26 | 2.12 | 1.77 | 1.47 | 2.08 |
| PBT / Share (Rs.) | 0.31 | 0.60 | 0.31 | 0.26 | 0.59 |
| Net Profit / Share (Rs.) | 0.23 | 0.44 | 0.24 | 0.20 | 0.44 |
| PBDIT Margin (%) | 2.15 | 2.91 | 2.42 | 1.56 | 2.57 |
| PBIT Margin (%) | 1.42 | 2.41 | 2.05 | 1.27 | 2.17 |
| PBT Margin (%) | 0.36 | 0.68 | 0.37 | 0.23 | 0.62 |
| Net Profit Margin (%) | 0.26 | 0.50 | 0.28 | 0.17 | 0.46 |
| Return on Networth / Equity (%) | 1.10 | 1.88 | 1.03 | 0.87 | 1.93 |
| Return on Capital Employeed (%) | 5.69 | 8.39 | 7.22 | 5.84 | 9.05 |
| Return On Assets (%) | 0.60 | 0.89 | 0.52 | 0.43 | 1.08 |
| Long Term Debt / Equity (X) | 0.01 | 0.06 | 0.05 | 0.08 | 0.00 |
| Total Debt / Equity (X) | 0.46 | 0.80 | 0.71 | 0.86 | 0.73 |
| Asset Turnover Ratio (%) | 2.44 | 1.83 | 1.87 | 2.65 | 2.22 |
| Current Ratio (X) | 1.93 | 1.85 | 1.89 | 2.09 | 2.16 |
| Quick Ratio (X) | 1.27 | 1.14 | 1.16 | 1.42 | 1.44 |
| Inventory Turnover Ratio (X) | 7.69 | 3.72 | 4.74 | 7.82 | 6.82 |
| Interest Coverage Ratio (X) | 2.03 | 1.68 | 1.44 | 1.51 | 1.66 |
| Interest Coverage Ratio (Post Tax) (X) | 1.25 | 1.29 | 1.17 | 1.17 | 1.30 |
| Enterprise Value (Cr.) | 49.65 | 66.52 | 61.28 | 70.59 | 62.18 |
| EV / Net Operating Revenue (X) | 0.21 | 0.43 | 0.41 | 0.35 | 0.37 |
| EV / EBITDA (X) | 10.05 | 15.09 | 17.00 | 22.70 | 14.64 |
| MarketCap / Net Operating Revenue (X) | 0.10 | 0.22 | 0.22 | 0.18 | 0.20 |
| Price / BV (X) | 0.41 | 0.82 | 0.81 | 0.90 | 0.84 |
| Price / Net Operating Revenue (X) | 0.10 | 0.22 | 0.22 | 0.18 | 0.20 |
| EarningsYield | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 |
After reviewing the key financial ratios for Sanginita Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.24. This value is below the healthy minimum of 5. It has decreased from 0.45 (Mar 24) to 0.24, marking a decrease of 0.21.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.24. This value is below the healthy minimum of 5. It has decreased from 0.45 (Mar 24) to 0.24, marking a decrease of 0.21.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 3. It has increased from 0.87 (Mar 24) to 0.88, marking an increase of 0.01.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 21.68. It has decreased from 23.62 (Mar 24) to 21.68, marking a decrease of 1.94.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 21.68. It has decreased from 23.62 (Mar 24) to 21.68, marking a decrease of 1.94.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 88.67. It has increased from 87.74 (Mar 24) to 88.67, marking an increase of 0.93.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.91. This value is below the healthy minimum of 2. It has decreased from 2.55 (Mar 24) to 1.91, marking a decrease of 0.64.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 2.12 (Mar 24) to 1.26, marking a decrease of 0.86.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.31. This value is within the healthy range. It has decreased from 0.60 (Mar 24) to 0.31, marking a decrease of 0.29.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 2. It has decreased from 0.44 (Mar 24) to 0.23, marking a decrease of 0.21.
- For PBDIT Margin (%), as of Mar 25, the value is 2.15. This value is below the healthy minimum of 10. It has decreased from 2.91 (Mar 24) to 2.15, marking a decrease of 0.76.
- For PBIT Margin (%), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 10. It has decreased from 2.41 (Mar 24) to 1.42, marking a decrease of 0.99.
- For PBT Margin (%), as of Mar 25, the value is 0.36. This value is below the healthy minimum of 10. It has decreased from 0.68 (Mar 24) to 0.36, marking a decrease of 0.32.
- For Net Profit Margin (%), as of Mar 25, the value is 0.26. This value is below the healthy minimum of 5. It has decreased from 0.50 (Mar 24) to 0.26, marking a decrease of 0.24.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.10. This value is below the healthy minimum of 15. It has decreased from 1.88 (Mar 24) to 1.10, marking a decrease of 0.78.
- For Return on Capital Employeed (%), as of Mar 25, the value is 5.69. This value is below the healthy minimum of 10. It has decreased from 8.39 (Mar 24) to 5.69, marking a decrease of 2.70.
- For Return On Assets (%), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 5. It has decreased from 0.89 (Mar 24) to 0.60, marking a decrease of 0.29.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 24) to 0.01, marking a decrease of 0.05.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.46. This value is within the healthy range. It has decreased from 0.80 (Mar 24) to 0.46, marking a decrease of 0.34.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.44. It has increased from 1.83 (Mar 24) to 2.44, marking an increase of 0.61.
- For Current Ratio (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has increased from 1.85 (Mar 24) to 1.93, marking an increase of 0.08.
- For Quick Ratio (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has increased from 1.14 (Mar 24) to 1.27, marking an increase of 0.13.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.69. This value is within the healthy range. It has increased from 3.72 (Mar 24) to 7.69, marking an increase of 3.97.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.03. This value is below the healthy minimum of 3. It has increased from 1.68 (Mar 24) to 2.03, marking an increase of 0.35.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.25. This value is below the healthy minimum of 3. It has decreased from 1.29 (Mar 24) to 1.25, marking a decrease of 0.04.
- For Enterprise Value (Cr.), as of Mar 25, the value is 49.65. It has decreased from 66.52 (Mar 24) to 49.65, marking a decrease of 16.87.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 1. It has decreased from 0.43 (Mar 24) to 0.21, marking a decrease of 0.22.
- For EV / EBITDA (X), as of Mar 25, the value is 10.05. This value is within the healthy range. It has decreased from 15.09 (Mar 24) to 10.05, marking a decrease of 5.04.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 1. It has decreased from 0.22 (Mar 24) to 0.10, marking a decrease of 0.12.
- For Price / BV (X), as of Mar 25, the value is 0.41. This value is below the healthy minimum of 1. It has decreased from 0.82 (Mar 24) to 0.41, marking a decrease of 0.41.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 1. It has decreased from 0.22 (Mar 24) to 0.10, marking a decrease of 0.12.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sanginita Chemicals Ltd:
- Net Profit Margin: 0.26%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 5.69% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.1% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.25
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 405.73)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.46
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.26%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | No.301, 3rd Floor, Gandhinagar Gujarat 382011 | sanginitachemicals@yahoo.com http://www.sanginitachemicals.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dineshsinh B Chavada | Chairperson & Managing Director |
| Mr. Vijaysinh D Chavda | Whole Time Director |
| Mr. Faiyazkhan Y Pathan | Independent Director |
| Mr. Jagdishkumar V Thakor | Independent Director |
| Mr. Pramodsinh D Dabhi | Independent Director |
| Mrs. Hansaben D Chavda | Director |
FAQ
What is the intrinsic value of Sanginita Chemicals Ltd?
Sanginita Chemicals Ltd's intrinsic value (as of 20 October 2025) is 3.35 which is 68.69% lower the current market price of 10.70, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 27.8 Cr. market cap, FY2025-2026 high/low of 17.2/8.46, reserves of ₹30 Cr, and liabilities of 102 Cr.
What is the Market Cap of Sanginita Chemicals Ltd?
The Market Cap of Sanginita Chemicals Ltd is 27.8 Cr..
What is the current Stock Price of Sanginita Chemicals Ltd as on 20 October 2025?
The current stock price of Sanginita Chemicals Ltd as on 20 October 2025 is 10.7.
What is the High / Low of Sanginita Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Sanginita Chemicals Ltd stocks is 17.2/8.46.
What is the Stock P/E of Sanginita Chemicals Ltd?
The Stock P/E of Sanginita Chemicals Ltd is .
What is the Book Value of Sanginita Chemicals Ltd?
The Book Value of Sanginita Chemicals Ltd is 21.4.
What is the Dividend Yield of Sanginita Chemicals Ltd?
The Dividend Yield of Sanginita Chemicals Ltd is 0.00 %.
What is the ROCE of Sanginita Chemicals Ltd?
The ROCE of Sanginita Chemicals Ltd is 4.19 %.
What is the ROE of Sanginita Chemicals Ltd?
The ROE of Sanginita Chemicals Ltd is 1.28 %.
What is the Face Value of Sanginita Chemicals Ltd?
The Face Value of Sanginita Chemicals Ltd is 10.0.